1,247
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Supplementation with a fish protein hydrolysate (Micromesistius poutassou): effects on body weight, body composition, and CCK/GLP-1 secretion

, , , , &
Article: 29857 | Received 24 Sep 2015, Accepted 22 Dec 2015, Published online: 29 Jan 2016

References

  • Benjakul S, Yarnpakdee S, Senphan T, Halldorsdottir SM, Kristinsson HG. Fish protein hydrolysates: production, bioactivities and applications. 2014; Reykjavik, Iceland: Matil Ltd. 237–83. In: Kristinsson HG, ed. Antioxidants and functional components in aquatic foods, 1st ed..
  • Moller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr. 2008; 47: 171–82.
  • Hatanaka A, Miyahara H, Suzuki KI, Sato S. Isolation and identification of antihypertensive peptides from Antarctic krill tail meat hydrolysate. J Food Sci. 2009; 74: H116–20.
  • Kim SK, Ngo DH, Vo TS. Marine fish-derived bioactive peptides as potential antihypertensive agents. Adv Food Nutr Res. 2012; 65: 249–60.
  • Li Y, Zhou J, Huang K, Sun Y, Zeng X. Purification of a novel angiotensin I converting enzyme (ACE) inhibitory peptide with an antihypertensive effect from loach (Misgurnus anguillicaudatus). J Agric Food Chem. 2012; 60: 1320–5.
  • Ngo DH, Ryu B, Vo TS, Himaya SW, Wijesekara I, Kim SK. Free radical scavenging and angiotensin-I converting enzyme inhibitory peptides from Pacific cod (Gadus macrocephalus) skin gelatin. Int J Biol Macromol. 2011; 49: 1110–16.
  • Nazeer RA, Sampath Kumar NS, Jai Ganesh R. In vitro and in vivo studies on the antioxidant activity of fish peptide isolated from the croaker (Otolithes ruber) muscle protein hydrolysate. Peptides. 2012; 35: 261–8.
  • Najafian L, Babji AS. A review of fish-derived antioxidant and antimicrobial peptides: their production, assessment, and applications. Peptides. 2012; 33: 178–85.
  • Sampath Kumar NS, Nazeer RA, Jaiganesh R. Purification and identification of antioxidant peptides from the skin protein hydrolysate of two marine fishes, horse mackerel (Magalaspis cordyla) and croaker (Otolithes ruber). Amino Acids. 2012; 42: 1641–9.
  • Yang R, Wang J, Liu Z, Pei X, Han X, Li Y. Antioxidant effect of a marine oligopeptide preparation from chum salmon (Oncorhynchus keta) by enzymatic hydrolysis in radiation injured mice. Mar Drugs. 2011; 9: 2304–15.
  • Duarte J, Vinderola G, Ritz B, Perdigon G, Matar C. Immunomodulating capacity of commercial fish protein hydrolysate for diet supplementation. Immunobiology. 2006; 211: 341–50.
  • Fitzgerald AJ, Rai PS, Marchbank T, Taylor GW, Ghosh S, Ritz BW, etal. Reparative properties of a commercial fish protein hydrolysate preparation. Gut. 2005; 54: 775–81.
  • Marchbank T, Limdi JK, Mahmood A, Elia G, Playford RJ. Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury. Aliment Pharmacol Ther. 2008; 28: 799–804.
  • Rigamonti E, Parolini C, Marchesi M, Diani E, Brambilla S, Sirtori CR, etal. Hypolipidemic effect of dietary pea proteins: impact on genes regulating hepatic lipid metabolism. Mol Nutr Food Res. 2010; 54(Suppl 1): S24–30.
  • Sugiyama K, Ohkawa S, Muramatsu K. Relationship between amino acid composition of diet and plasma cholesterol level in growing rats fed a high cholesterol diet. J Nutr Sci Vitaminol (Tokyo). 1986; 32: 413–23.
  • Shukla A, Bettzieche A, Hirche F, Brandsch C, Stangl GI, Eder K. Dietary fish protein alters blood lipid concentrations and hepatic genes involved in cholesterol homeostasis in the rat model. Br J Nutr. 2006; 96: 674–82.
  • Bjørndal B, Berge C, Ramsvik MS, Svardal A, Bohov P, Skorve J, etal. A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation. Lipids Health Dis. 2013; 12: 143.
  • Williams DL, Baskin DG, Schwartz MW. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes. 2006; 55(12): 3387–93.
  • Hisadome K, Reimann F, Gribble FM, Trapp S. Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like peptide 1 neurons. Diabetes. 2010; 59: 1890–98.
  • Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, etal. Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol. 2000; 423: 261–81.
  • Kopin A, Foulds MW, McBride EW, Nguyen M, Al-Haider W, Schmitz F, etal. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest. 1999; 103: 383–91.
  • Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, etal. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med. 1996; 2(11): 1254–8.
  • Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 1996; 381(6581): 415–21.
  • Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992; 41: 1422–8.
  • World Health Organization. Fact sheet 311 – obesity and overweight. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/ [cited 21 December 2015].
  • Cudennec B, Ravallec-Plé R, Courois E, Fouchereau-Peron M. Peptides from fish and crustacean by-products hydrolysates stimulate cholecystokinin release in STC-1 cells. Food Chem. 2008; 111(4): 970–5.
  • Cudennec B, Fouchereau-Peron M, Ferry F, Duclos E, Ravallec R. In vitro and in vivo evidence for a satiating effect of fish protein hydrolysate obtained from blue whiting (Micromesistius poutassou) muscle. J Func Foods. 2012; 4(1): 271–7.
  • Zaïr Y, Duclos E, Housez B, Vergara C, Cazaubiel M, Soisson F. Evaluation of the satiating properties of a fish protein hydrolysate among overweight women: a pilot study. Nutr Food Sci. 2014; 44(5): 389–99.
  • NIH Consensus Statement. Bioelectrical impedance analysis in body composition measurement: National Institute of Health Technology Assessment Conference Statement. December 12–14, 1994. Nutrition 1996; 12: 749–62.
  • National Health and Nutrition Examination Survey III. Body measurements (anthropometry). 1998; Rockville, MD: Westat.
  • Pirke KM, Kellner MB, Friess E, Krieg JC, Fichter MM. Satiety and cholecystokinin. Int J Eat Disord. 1994; 15: 63–9.
  • Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism. 1993; 42: 581–4.
  • Näslund E, Melin I, Grybäck P, Hägg A, Hellström PM, Jacobsson H, etal. Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr. 1997; 66: 26–32.